Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

22nd Apr 2025 11:20

RNS Number : 6885F
Eurocell plc
22 April 2025
 

22 April 2025

 

EUROCELL PLC

(the "Company")

 

Director/PDMR Shareholding

 

Eurocell plc (the "Company") announces that, on 17 April 2025:

· options granted on 13 April 2022 under the Eurocell plc Deferred Share Plan 2015, to acquire ordinary shares in the Company, were exercised by a director; and

· shares acquired, as a result of the above exercise, were sold by the above director to cover the associated tax and national insurance liabilities.

 

The notifications set out below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Michael Scott

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Exercise of nil-cost options to acquire ordinary shares under the Eurocell plc Deferred Share Plan 2015

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£nil (option price)

34,079

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A - single transactions

e)

Date of the transaction

17 April 2025

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Michael Scott

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Sale of ordinary shares, acquired under the Eurocell plc Deferred Share Plan 2015, to cover the associated tax and national insurance liabilities

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.495

16,099

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A - single transactions

e)

Date of the transaction

17 April 2025

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

For further information:

 

Eurocell plc 01773 842 100

Vicky Williams

Group Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUQGCUPAGUP

Related Shares:

Eurocell
FTSE 100 Latest
Value8,610.26
Change55.46